Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHOGUN: S-1 and oxaliplatin with radiation for rectal cancer
NCT01227239Phase 2Unknown
- Sponsor
- Japan Clinical Cancer Research Organization
- Start
- Sep 2010
- Primary completion
- Aug 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in Rectal cancer (RC), sponsored by Japan Clinical Cancer Research Organization. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
Rectal cancer (RC)
Beyond the preview
Go deeper on NCT01227239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227239.